Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects

NCT05742984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: linaprazan glurate 25 mg QD
DRUG: linaprazan glurate 50 mg QD
DRUG: linaprazan glurate 75 mg QD
DRUG: linaprazan glurate 25 mg BID
DRUG: linaprazan glurate 50 mg BID
DRUG: linaprazan glurate 75 mg BID

Sponsor

Cinclus Pharma Holding AB